Taiwan FDA registration 098103ce7ca63caae63e9945a85ff6fa

"100 first" follicular stimulating hormone radioimmunoassay reagents

TW: “百首”濾泡刺激激素放射免疫分析試劑
Taiwan flagTaiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Feb 19, 2009 – Feb 19, 2029Active
Registration details
Analysis ID
098103ce7ca63caae63e9945a85ff6fa
Customs Code
DHAS0601994703
Company information
Manufacturer Country
Belgium
Authorized Representative
TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
Intended Use
For in vitro quantitative detection of follicular stimulating hormone (FSH) in human serum and plasma.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1300 Follicular Stimulation Hormone Test System
Import Information
Input;; Consent letter must be attached to the import (each batch of imports should be accompanied by a certificate of approval by the Atomic Energy Commission)
Dates and status
Registration Date
Feb 19, 2009
Expiry Date
Feb 19, 2029
About this record

Access comprehensive regulatory information for "100 first" follicular stimulating hormone radioimmunoassay reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 098103ce7ca63caae63e9945a85ff6fa and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices